Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life
Not yet recruitingOBSERVATIONAL
Enrollment
500
Participants
Timeline
Start Date
December 1, 2023
Primary Completion Date
December 1, 2024
Study Completion Date
December 1, 2024
Conditions
Nasopharyngeal Carcinoma
Trial Locations (1)
350014
Department of radiation oncology, Fujian cancer hospital, Fuzhou
All Listed Sponsors
lead
Fujian Cancer Hospital
OTHER_GOV
NCT06136962 - Nasopharyngeal Carcinoma Treated With Reduced Volume Intensity Modulated Radiation Therapy:10-Year Outcome and Late Toxicity, Quality of Life | Biotech Hunter | Biotech Hunter